Wela Strategies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,128
Closed -$679K 57
2025
Q2
$679K Buy
6,128
+303
+5% +$32.2K 0.27% 30
2025
Q1
$653K Sell
5,825
-850
-13% -$87.7K 0.28% 26
2024
Q4
$617K Buy
6,675
+816
+14% +$73.5K 0.27% 28
2024
Q3
$491K Buy
5,859
+187
+3% +$14.3K 0.21% 30
2024
Q2
$389K Buy
5,672
+266
+5% +$17.8K 0.18% 43
2024
Q1
$396K Buy
5,406
+525
+11% +$40.4K 0.19% 42
2023
Q4
$395K Buy
4,881
+229
+5% +$17.8K 0.21% 37
2023
Q3
$349K Buy
4,652
+61
+1% +$4.69K 0.21% 38
2023
Q2
$354K Buy
4,591
+19
+0.4% +$1.51K 0.27% 32
2023
Q1
$379K Sell
4,572
-844
-16% -$69.9K 0.2% 35
2022
Q4
$465K Buy
5,416
+319
+6% +$25.3K 0.26% 28
2022
Q3
$314K Buy
5,097
+377
+8% +$23.8K 0.21% 32
2022
Q2
$292K Buy
4,720
+140
+3% +$8.67K 0.17% 33
2022
Q1
$272K Buy
4,580
+271
+6% +$17.3K 0.14% 40
2021
Q4
$313K Buy
4,309
+132
+3% +$9.09K 0.15% 34
2021
Q3
$292K Sell
4,177
-46
-1% -$3.23K 0.15% 33
2021
Q2
$291K Buy
4,223
+140
+3% +$9.35K 0.12% 36
2021
Q1
$264K Buy
+4,083
New +$263K 0.14% 38
2020
Q4
Sell
-3,252
Closed -$205K 42
2020
Q3
$205K Buy
+3,252
New +$226K 0.13% 40

Other funds holding GILD

Wela Strategies's GILD Position: Q3 2025 in Review

Wela Strategies sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 6,128 shares — an estimated $679K sold.

Wela Strategies first reported a position in GILD in Q3 2020 and held it in 19 quarters. The position peaked at $679K in Q2 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Wela Strategies reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Wela Strategies sold 6,128 Gilead Sciences shares in Q3 2025, an estimated $679K.
  • Wela Strategies first reported a position in Gilead Sciences in Q3 2020 and held it in 19 quarters.
  • Wela Strategies's Gilead Sciences position peaked at $679K in Q2 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Wela Strategies's 13F filing for Q3 2025, filed 24 Oct 2025.